Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes
The Journal of Gene Medicine · 2024
DOI: 10.1002/jgm.3694 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Xinyun Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Single-Cell Analysis, Lung Neoplasms, Immunotherapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: National Natural Science Foundation of China, foundation of Shanghai Pulmonary Hospital, Innovation Program of Shanghai Municipal Education Commission.
Abstract (Originalsprache)
Background
Immune checkpoint blockade has emerged as a key strategy to the therapy landscape of non‐small cell lung cancer (NSCLC). However, notable differences in immunotherapeutic outcomes exist between the two primary NSCLC subtypes: lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). This disparity may stem from the tumor immune microenvironment's heterogeneity at the transcriptome level.
Methods
By integrative analysis of transcriptomic characterization of 38 NSCLC patients by single‐cell RNA sequencing, the present study revealed a distinct tumor microenvironment (TME) between LUAD and LUSC, with relevant results further confirmed in bulk transcriptomic and multiplex immunofluorescence (mIF) validation cohort of neoadjuvant immunotherapy patients.
Results
LUAD exhibited a more active immune microenvironment compared to LUSC. This included highly expression of HLA I/II in cancer cells, reinforced antigen presentation potential of dendritic cells and enhanced cytotoxic activity observed in T/NK cells. In LUSC, cancer cells highly expressed genes belonging to the aldo‐keto reductases, glutathione S ‐transferases and aldehyde dehydrogenase family, negatively correlating with immunotherapy outcomes in the validation cohort of our center. Further analysis revealed elevated infiltrated cancer‐associated fibroblasts (CAFs) in LUSC, which was corroborated in The Cancer Genome Atlas cohort. Corresponding increased infiltration of ADH1B+ CAFs in major pathologic response (MPR) patients and the higher presence of FAP+ CAFs in non‐MPR patients were demonstrated by multiplex mIF. Moreover, upregulating immunosuppressive extracellular matrix remodeling was identified in LUSC.
Conclusions
These comprehensive analyses advance the understanding of the differences in TME between LUAD and LUSC, offering insights for patient selection and developing subtype‐specific treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
- foundation of Shanghai Pulmonary Hospital
- Innovation Program of Shanghai Municipal Education Commission
Zitieren
APA
Fang, X., Li, D., Wan, S., Hu, J., Zhang, P., Jie, D., Chen, L., Jiang, G., & Song, N. (2024). Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3694
Vancouver
Fang X, Li D, Wan S, Hu J, Zhang P, Jie D, et al. Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3694
BibTeX
@article{Fang2024,
author = {Fang, Xinyun and Li, Dianke and Wan, Shiyue and Hu, Junjie and Zhang, Peng and Jie, Dai and Chen, Linsong and Jiang, Gening and Song, Nan},
title = {Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single‐cell transcriptomic analysis: Implications for distinct immunotherapy outcomes},
journal = {The Journal of Gene Medicine},
year = {2024},
doi = {10.1002/jgm.3694}
}
EUVIMED